Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Tobramycin exposure from active calcium sulfate bone graft substitute.

Livio F, Wahl P, Csajka C, Gautier E, Buclin T.

BMC Pharmacol Toxicol. 2014 Mar 4;15:12. doi: 10.1186/2050-6511-15-12.

PMID:
24593819
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Systemic exposure to tobramycin after local antibiotic treatment with calcium sulphate as carrier material.

Wahl P, Livio F, Jacobi M, Gautier E, Buclin T.

Arch Orthop Trauma Surg. 2011 May;131(5):657-62. doi: 10.1007/s00402-010-1192-2. Epub 2010 Oct 12.

PMID:
20938669
[PubMed - indexed for MEDLINE]
3.

Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.

Conil JM, Georges B, Ruiz S, Rival T, Seguin T, Cougot P, Fourcade O, Pharmd GH, Saivin S.

Br J Clin Pharmacol. 2011 Jan;71(1):61-71. doi: 10.1111/j.1365-2125.2010.03793.x.

PMID:
21143502
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets.

Turner TM, Urban RM, Hall DJ, Chye PC, Segreti J, Gitelis S.

Clin Orthop Relat Res. 2005 Aug;(437):97-104.

PMID:
16056033
[PubMed - indexed for MEDLINE]
5.

Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis.

Hennig S, Standing JF, Staatz CE, Thomson AH.

Clin Pharmacokinet. 2013 Apr;52(4):289-301. doi: 10.1007/s40262-013-0036-y.

PMID:
23420517
[PubMed - indexed for MEDLINE]
6.

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.

Hennig S, Norris R, Kirkpatrick CM.

Br J Clin Pharmacol. 2008 Apr;65(4):502-10. Epub 2007 Nov 8.

PMID:
17995972
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Creatinine clearance as predictor of tobramycin elimination in adult patients with cystic fibrosis.

Town DJ, Vinks AA, Jacobs F, Heijerman HG, Bakker W.

Ther Drug Monit. 1996 Oct;18(5):562-9.

PMID:
8885120
[PubMed - indexed for MEDLINE]
9.

Suboptimal aminoglycoside dosing in critically ill patients.

Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H.

Ther Drug Monit. 2008 Dec;30(6):674-81. doi: 10.1097/FTD.0b013e31818b6b2f.

PMID:
19057371
[PubMed - indexed for MEDLINE]
10.

Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.

Jacobson PA, West NJ, Price J, Hutchinson RJ.

Ann Pharmacother. 1997 Oct;31(10):1127-31.

PMID:
9337435
[PubMed - indexed for MEDLINE]
11.

Adult osteomyelitis: debridement versus debridement plus Osteoset T pellets.

Chang W, Colangeli M, Colangeli S, Di Bella C, Gozzi E, Donati D.

Acta Orthop Belg. 2007 Apr;73(2):238-43.

PMID:
17515238
[PubMed - indexed for MEDLINE]
12.

[Effect evaluation of medical calcium sulfate--OsteoSet in repairing jaw bone defect].

Zheng X, He J.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Jan;26(1):87-90. Chinese.

PMID:
22332527
[PubMed - indexed for MEDLINE]
13.

The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial.

McKee MD, Wild LM, Schemitsch EH, Waddell JP.

J Orthop Trauma. 2002 Oct;16(9):622-7.

PMID:
12368641
[PubMed - indexed for MEDLINE]
14.

Treatment of infected tibial nonunion with tobramycin-impregnated calcium sulfate: report of two cases.

Tsai YH, Tsung-Jen H, Shih HN, Hsu RW.

Chang Gung Med J. 2004 Jul;27(7):542-7.

PMID:
15508877
[PubMed - indexed for MEDLINE]
Free Article
15.

Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.

Nandy P, Samtani MN, Lin R.

Antimicrob Agents Chemother. 2010 Jun;54(6):2354-9. doi: 10.1128/AAC.01649-09. Epub 2010 Apr 12.

PMID:
20385854
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

In vitro analysis of the elution of tobramycin from a calcium sulfate bone void filler.

Pietrzak WS, Eppley BL.

J Craniofac Surg. 2004 Sep;15(5):752-7.

PMID:
15346013
[PubMed - indexed for MEDLINE]
17.

Population kinetics of tobramycin in neonates.

Falcão AC, Buelga DS, Méndez ME, García MJ, Pardo M.

Ther Drug Monit. 2001 Jun;23(3):202-8.

PMID:
11360026
[PubMed - indexed for MEDLINE]
18.

Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis.

Cooney GF, Lum BL, Tomaselli M, Fiel SB.

J Clin Pharmacol. 1994 Mar;34(3):255-9.

PMID:
8021334
[PubMed - indexed for MEDLINE]
19.

[Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].

Reimann IR, Meier-Hellmann A, Pfeifer R, Traut T, Schilling A, Stein G, Reinhart K, Hoffmann A.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 May;34(5):288-95. German.

PMID:
10372218
[PubMed - indexed for MEDLINE]
20.

Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulation.

Peris-Marti JF, Borras-Blasco J, Rosique-Robles JD, Gonzalez-Delgado M.

J Clin Pharm Ther. 2004 Feb;29(1):65-70.

PMID:
14748900
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk